NYSONDAR Trademark

Trademark Overview


On Thursday, April 8, 2010, a trademark application was filed for NYSONDAR with the United States Patent and Trademark Office. The USPTO has given the NYSONDAR trademark a serial number of 85009766. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 27, 2017. This trademark is owned by Glaxo Group Limited. The NYSONDAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
nysondar

General Information


Serial Number85009766
Word MarkNYSONDAR
Filing DateThursday, April 8, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 27, 2017
Registration Number3933954
Registration DateTuesday, March 22, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2011

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Friday, October 27, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, March 22, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 22, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, January 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2011PUBLISHED FOR OPPOSITION
Monday, November 29, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 17, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 16, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 16, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 16, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 16, 2010ASSIGNED TO LIE
Monday, November 1, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 28, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 28, 2010LETTER OF SUSPENSION E-MAILED
Thursday, October 28, 2010SUSPENSION LETTER WRITTEN
Wednesday, October 27, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 27, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 27, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 27, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 14, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2010NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2010NON-FINAL ACTION WRITTEN
Tuesday, July 13, 2010ASSIGNED TO EXAMINER
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 12, 2010NEW APPLICATION ENTERED IN TRAM